Google is updating its image generator to make it faster and cheaper, making it a more useful tool for creators looking to ...

A year ago, turning a written idea into a finished video meant a camera, a timeline editor, and hours of work. Today, a ...

But for all the effort those literary types put into their fictional maps, there’s probably never been anyone quite like . As ...

From plotting routes to revealing traffic light locations, these free navigation services continue to evolve with new features. But which is tops? I tested both map apps and found a clear winner. My ...

Last month, Google quietly killed off Google Sky Maps. But there’s still another way to virtually explore most of the solar system a la Google Maps: it’s called Google Maps in Space. Google Maps in ...

If the lights go out again, here's what Austin residents need to know. Texas has experienced a growing number of weather-related power outages in recent years. Experts told The Texas Tribune that the ...

Burmese pythons are an invasive species in Florida, primarily established in the Everglades and South Florida. These snakes have drastically reduced native mammal populations, including raccoons, ...

It's been only a few months since OpenAI released its last big improvement to AI image generations in ChatGPT and through its application programming interface (API) — namely, a new image generation ...

Recent disruptions to oil supply in the Middle East have sent energy prices soaring, reminding countries how vulnerable they remain to imported fossil fuels. At the same time, global electricity ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...